Cargando…

1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy

Detalles Bibliográficos
Autores principales: Hempel, D., Milani, V., Kleespies, A., Hempel, L., Ebner, F., Zehn, D., Keim, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506367/
http://dx.doi.org/10.1016/j.annonc.2020.08.1744
_version_ 1783585002197352448
author Hempel, D.
Milani, V.
Kleespies, A.
Hempel, L.
Ebner, F.
Zehn, D.
Keim, S.
author_facet Hempel, D.
Milani, V.
Kleespies, A.
Hempel, L.
Ebner, F.
Zehn, D.
Keim, S.
author_sort Hempel, D.
collection PubMed
description
format Online
Article
Text
id pubmed-7506367
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75063672020-09-23 1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy Hempel, D. Milani, V. Kleespies, A. Hempel, L. Ebner, F. Zehn, D. Keim, S. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506367/ http://dx.doi.org/10.1016/j.annonc.2020.08.1744 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hempel, D.
Milani, V.
Kleespies, A.
Hempel, L.
Ebner, F.
Zehn, D.
Keim, S.
1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
title 1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
title_full 1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
title_fullStr 1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
title_full_unstemmed 1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
title_short 1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
title_sort 1680p sars-cov-2 infections in outpatients with cancer: most infected patients are asymptomatic carriers without impact on chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506367/
http://dx.doi.org/10.1016/j.annonc.2020.08.1744
work_keys_str_mv AT hempeld 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy
AT milaniv 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy
AT kleespiesa 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy
AT hempell 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy
AT ebnerf 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy
AT zehnd 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy
AT keims 1680psarscov2infectionsinoutpatientswithcancermostinfectedpatientsareasymptomaticcarrierswithoutimpactonchemotherapy